GSK board backs CEO Walmsley in dispute: She is ‘the right leader of New GSK’
GlaxoSmithKline CEO Emma Walmsley is getting a big sign of support in a growing dispute with an activist hedge fund that has hinted Walmsley should be replaced.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
